Antimicrobials new and old molecules in the fight against multi-resistant bacteria

Reports on the emergence and prevalence of resistant bacterial infections in hospitals and communities raise concerns that we may soon no longer be able to rely on antibiotics as a way to control infectious diseases. Effective medical care would require the constant introduction of novel antibiotics...

Full description

Saved in:
Bibliographic Details
Other Authors: Marinelli, Flavia (Editor), Genilloud, Olga (Editor)
Format: Book
Language:English
Published: Heidelberg Springer 2014
Subjects:
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000#i 4501
001 wils-523677
005 2021029164245
008 210129t2014 GW a# #001 deng D
020 # # |a 9783642399671  |q hardback 
020 # # |a 3642399673  |q hardback 
040 # # |a DNLM  |b eng  |c DNLM  |d UiTM  |e rda 
041 0 # |a English 
060 0 0 |a QV 350 
090 0 0 |a QV350  |b A631 2014 
245 0 0 |a Antimicrobials  |b new and old molecules in the fight against multi-resistant bacteria  |c Flavia Marinelli, Olga Genilloud, editors 
264 # 1 |a Heidelberg  |b Springer  |c 2014 
264 # 4 |c ©2014 
300 # # |a viii, 364 pages  |b illustrations  |c 24 cm 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a unmediated  |b n  |2 rdamedia 
338 # # |a volume  |b nc  |2 rdacarrier 
504 # # |a Includes bibliographical references and index 
520 # # |a Reports on the emergence and prevalence of resistant bacterial infections in hospitals and communities raise concerns that we may soon no longer be able to rely on antibiotics as a way to control infectious diseases. Effective medical care would require the constant introduction of novel antibiotics to keep up in the "arms race" with resistant pathogens. This book closely examines the latest developments in the field of antibacterial research and development. It starts with an overview of the growing prevalence of resistant Gram-positive and Gram-negative pathogens, including their various resistance mechanisms, prevalence, risk factors and therapeutic options. The focus then shifts to a comprehensive description of all major chemical classes with antibacterial properties, their chemistry, mode of action, and the generation of analogs; information that provides the basis for the design of improved molecules to defeat microbial infections and combat the emerging resistances. In closing, recently developed compounds already in clinical use, those in preclinical or first clinical studies, and a number of promising targets to be exploited in the discovery stage are discussed 
650 1 2 |a Anti-Bacterial Agents  |x chemistry 
650 2 2 |a Community-Acquired Infections  |x etiology 
650 2 2 |a Drug Resistance, Bacterial 
700 1 # |a Marinelli, Flavia  |e editor 
700 1 # |a Genilloud, Olga  |e editor 
856 4 0 |z Click Here to View Status and Holdings.  |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=523677